Papers
16
Total Citations
295
H-Index
7
About
Robert Timmerman is a radiation oncologist whose research has significantly advanced the field of stereotactic body radiation therapy (SBRT) and radiosurgery, with particular expertise in precision-guided, hypofractionated treatment approaches across multiple cancer sites. His work has been instrumental in refining how high-dose, ablative radiation can be delivered safely and effectively to tumors in the breast, lung, brain, and larynx. Timmerman's most impactful contributions center on stereotactic partial breast irradiation (S-PBI), where his phase 1 dose-escalation trials — spanning 5-fraction and single-fraction approaches — have helped establish feasibility, safety, and promising cosmetic outcomes for early-stage breast cancer patients (collectively accumulating nearly 115 citations). His comparative dosimetric analyses of robotic versus conventional linac-based SBRT systems have provided clinicians with critical planning guidance, influencing how institutions select and optimize their delivery platforms. His work on multi-staged robotic radiosurgery for large cerebral arteriovenous malformations and pediatric brain tumor radiotherapy further demonstrates his commitment to expanding precision radiation into complex and vulnerable patient populations. Through rigorous clinical trial design and technical innovation, Timmerman has helped move SBRT from experimental to standard-of-care consideration across a remarkably broad range of indications.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10